BCL2 and intervertebral disk degenerative disorder: The experimental results showed that TR155 was able to alleviate the degeneration of intervertebral disc tissue and inhibit nucleus pulposus cell apoptosis via Bcl‐2/Bax pathway, indicating its potential to be a promising option for the treatment of IDD.